Management of Multiple Sclerosis | Page 2Amy Perrin RossCNRNMSCN
Fatigue, as one of the most frequent symptoms in patients with multiple sclerosis (MS), has various adverse effects on the physical and mental health-related quality of life (PCS, MCS) of patients. The aim of this study was to explore whether coping mediates the relationship between fatigue ...
我要写书评 Diagnosis and Management of Multiple Sclerosis的书评 ··· ( 全部0 条 ) 论坛 ··· 在这本书的论坛里发言 + 加入购书单 谁读这本书? ··· 二手市场 ··· 在豆瓣转让 手里有一本闲着? 订阅关于Diagnosis and Management of Multiple Sclerosis的评论: feed: rss 2.0©...
The long disease duration of multiple sclerosis and the increasing therapeutic options require a individualized therapeutic approach which should be carefully documented over years of observation. To switch from MS documentation to an innovative MS management, new computer- and internet-based tools could ...
Multiple sclerosis. Current concepts in management 来自 掌桥科研 喜欢 0 阅读量: 28 作者: B Giesser 展开 摘要: Multiple sclerosis is a chronic, often progressive disease of the central nervous system which can produce visual, sensory, motor, and genitourinary dysfunction. Although there is ...
Multiple sclerosis (MS) is the commonest cause of disability in young adults. While there is increasing choice and better treatments available for delaying disease progression, there are still, very few, effective symptomatic treatments. For many patients such as those with primary progressive MS (...
Presently, the course of multiple sclerosis (MS) can be altered little, if at all. Appropriate symptom management, however, can change the course of lives and allow for more comfortable, healthier living despite significant disease. Symptoms in MS are divided into three broad categories. Those th...
13. Rossini PM, Pasqualetti P, Pozzilli C, et al. Fatigue in progressive multiple sclerosis: results of a randomized, double-blind, placebo-controlled, crossover trial of oral 4-aminopyridine. Mult Scler J. 2001;7(6):354-358. doi:10.1177/135245850100700602 ...
Multiple sclerosis (MS) is a chronic demyelinating neurologic disorder that affects 2.5 million people worldwide, 400,000 of whom are in the United States. (1) Most people with MS are 20 to 50 years old, with rare cases occurring after age 65 years. (...
Symptomatic management con improve quality of life in multiple sclerosis (MS) patients. Although only few symptoms and signs completely disappear through symptomatic treatment, substantial relief is possible in most patients. Especially bladder dysfunction and pain syndromes require accurate diagnosis in orde...